RLJ Lodging Beat Earnings and Raised Guidance. The Stock Still Fell 6.6%. Here's Why That's Not a Problem for the Dividend.

RLJ Lodging Trust reported Q2 results that beat earnings, grew revenue by 6.8%, raised full-year guidance, and cleaned up its balance sheet. The stock fell 6.6% the next day.

The income investor needs to separate those two things immediately. One of them is about cash flow. The other is about price.

What actually happened in the quarter

Comparable RevPAR (revenue per available room, the operating scorecard for hotels) rose 6.8% to $167.15. That came from both price discipline and occupancy — average daily rate jumped 4.9% to $217.18, while occupancy climbed 1.8% to 77.0%. Business transient revenue grew 10%, and out-of-room ancillary spend followed. The CEO cited acceleration in business travel and strong urban leisure trends.

On the earnings side, adjusted FFO (a REIT cash-flow metric preferred over GAAP earnings because it strips out non-cash depreciation) came in at $0.52 per diluted share, up 8.3% year-over-year. Consensus had estimated only $0.14 — this wasn't a narrow beat, it was a blowout. Hotel EBITDA grew 7.1% to $119.5 million with a 31.3% margin.

Management raised full-year guidance across the board. RevPAR growth now runs +3.5% to +4.5% for the year. Comparable Hotel EBITDA guidance sits at $369 million to $389 million, and adjusted FFO per diluted share is now $1.37 to $1.50.

The balance sheet move was notable. On July 1, RLJ used $494 million in delayed-draw term loans plus cash on hand to fully repay its $500 million Senior Notes due 2026. Post-repayment, the company has $1 billion in total liquidity and no debt maturities until 2029, including extension options. Total debt sits at $2.2 billion against a $3.89 billion enterprise value.

Why the stock fell despite the good news

Because RLJ had already run up roughly 34% over the prior 120 days and nearly 50% year-to-date. The stock moved from $6.54 at its 52-week low to $12.89 at its 52-week high before this earnings release. The 6.6% selloff to $11.13 is a "sell the news" technical event — not a vote of no confidence on the business.

Margin expansion also disappointed some traders. Hotel EBITDA margin improved by only about 10 basis points (40 basis points excluding a prior-year tax benefit). That's not bad — 31.3% is a solid margin for a hotel REIT — but after a 34% rally, the market was looking for a step-change, not a continuation. What you're seeing is tape behavior on an overextended price, not a broken business.

The dividend is the part that matters

RLJ pays $0.15 per quarter on its common shares, or $0.60 annually. At $11.13, the common yield is 5.4%. There's also a Series A preferred share paying $0.4875 quarterly ($1.95 annually), which pays first and adds a layer of structural risk for common holders.

Here's the coverage math against the raised full-year guidance:

• At the midpoint of FFO guidance ($1.435 per share), the common dividend payout ratio is about 42%.
• At the low end ($1.37), it's 44%.
• At the high end ($1.50), it's 40%.

That is a well-covered dividend. You don't need the stock to keep rallying to keep the check writing. The business has significant room between what it earns and what it pays out.

Interest coverage reinforces the picture. Using the conservative end of Hotel EBITDA guidance ($369 million) against the high end of net interest expense guidance ($103 million), coverage sits at about 3.6x. That's solid for a hotel REIT with $2.2 billion in total debt and no maturities until 2029. The weighted average interest rate on corporate debt is 4.75%.

Trailing twelve-month free cash flow of $146 million covers the annual common dividend obligation of roughly $91 million by a factor of about 1.6x. The cash engine is bigger than the payout.

How this looks next to peers

RLJ trades at about 11.2x EV/EBITDA. Park Hotels & Resorts (PK) trades at roughly 32.6x. Ryman Hospitality (RHP) trades at 21.4x. Both peers are running at nearly double or triple the earnings multiple, reflecting RLJ's historically cheaper valuation relative to hotel REIT peers. RLJ also trades below book value at 0.79x P/B.

RLJ's common yield of 5.4% beats Park Hotels at 6.8% (which carries significantly higher leverage and risk) and Ryman at 3.9%. The yield gap here is real. The question for a portfolio is whether you want the extra income from RLJ at a deep valuation discount, or you prefer the quality premium that commands in a Ryman trade.

The risk case — and what would change my mind

The bear argument is about sustainability, not safety. Urban and event-driven hotel demand can turn quickly. RLJ's portfolio is concentrated in urban markets — Washington D.C., Chicago, New York. If business travel softens or group event pipelines dry up, RevPAR growth decelerates. The margin improvement story (only 10-40 basis points in Q2) suggests the company isn't printing money; it's growing through demand, not leverage.

The preferred share sits in front of common holders on the capital stack. If things get tight, the preferred keeps paying while common takes the hit. That's structural, not new.

What would weaken the income thesis materially? RevPAR growth falling back toward zero or negative territory, Hotel EBITDA margins compressing below 28%, or the company drawing on that $1 billion liquidity line for anything other than organic reinvestment. None of those are happening now.

What the income investor does with this

The lower price doesn't mean the cash-flow engine broke. It means the market pulled back from an overextended rally. The income engine is intact, coverage is solid, the balance sheet is cleaner, and the guidance is higher.

For an income portfolio already holding RLJ, there's nothing to do but hold. The dividend is safe at 42% coverage against raised guidance. The 5.4% yield at $11.13 is meaningful portfolio ballast.

For an income portfolio looking to add, this is the reinvestment moment the persona always talks about. A 6.6% pullback on a stock that delivers 5.4% yield, trades at 11x EBITDA (versus 32x for Park and 21x for Ryman), and has no maturities until 2029 is exactly the kind of entry that improves your portfolio yield without increasing risk. You're buying more future income on better terms because the tape got nervous after a big run.

If RevPAR growth stays at the low end of guidance or better, the stock likely recovers from here — and you'll be collecting that dividend while it does. If demand genuinely softens in the second half, you'll have entries at prices closer to $11 than the $12.89 high. Either way, the income stream is what was supposed to be intact, and it is.

That's what matters.